INZY   $4.0  0.25% Market Closed

Inozyme Pharma, Inc.
Total Cash 131.61M
totalCashPerShare 2.049
EBITDA -98.89M
Total Debt 46.79M
quickRatio 7.174
currentRatio 7.683
Total Revenue
debtToEquity 56.52
Revenue/Share
ROA -0.35691002
ROE -0.79419
grossProfits
freeCashflow -61.87M
operatingCashflow -91.21M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 176.64M
forwardPE -2.5636363
floatShares 35.86M
sharesOutstanding 67.10M
sharesShort 3.21M
sharesShortPriorMonth 3.93M
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.98%
Short Ratio help_outline 16.34%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 1.29
Price To Book help_outline 3.28
earningsQuarterlyGrowth
netIncomeToCommon -96.49M
trailingEps -1.55%
forwardEps -1.65%
enterpriseToEbitda -1.79
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.43 4Q 2024
institutionsCount 128
lastUpdated Nov. 7, 2024, 3:19 a.m.